298 related articles for article (PubMed ID: 31613314)
41. Thienorphine: receptor binding and behavioral effects in rhesus monkeys.
Li JX; Becker GL; Traynor JR; Gong ZH; France CP
J Pharmacol Exp Ther; 2007 Apr; 321(1):227-36. PubMed ID: 17220427
[TBL] [Abstract][Full Text] [Related]
42. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
Capasso A; Sorrentino L; Pinto A
Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
[TBL] [Abstract][Full Text] [Related]
43. Differential modulation by muscimol and baclofen on antinociception induced by morphine, beta-endorphin, D-Pen2,5-enkephalin and U50,488H administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Kim YH; Choi YS; Yoo JS; Tseng LF
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):614-9. PubMed ID: 9053732
[TBL] [Abstract][Full Text] [Related]
44. The role of kappa opioid receptors in stress-induced reinstatement of alcohol seeking in rats.
Funk D; Coen K; Lê AD
Brain Behav; 2014 May; 4(3):356-67. PubMed ID: 24944865
[TBL] [Abstract][Full Text] [Related]
45. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
46. Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats.
Henderson-Redmond A; Czachowski C
Psychopharmacology (Berl); 2014 Nov; 231(22):4309-21. PubMed ID: 24770627
[TBL] [Abstract][Full Text] [Related]
47. The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat.
Lindholm S; Werme M; Brené S; Franck J
Behav Brain Res; 2001 May; 120(2):137-46. PubMed ID: 11182162
[TBL] [Abstract][Full Text] [Related]
48. An antisense oligodeoxynucleotide to mu-opioid receptors inhibits mu-opioid receptor agonist-induced analgesia in rats.
Chen XH; Adams JU; Geller EB; DeRiel JK; Adler MW; Liu-Chen LY
Eur J Pharmacol; 1995 Feb; 275(1):105-8. PubMed ID: 7774656
[TBL] [Abstract][Full Text] [Related]
49. Ultrasonic vocalizations of preweanling rats: involvement of both alpha(2)-adrenoceptor and kappa-opioid receptor systems.
Nazarian A; Krall CM; Osburn JR; McDougall SA
Eur J Pharmacol; 2001 Mar; 415(2-3):165-71. PubMed ID: 11274995
[TBL] [Abstract][Full Text] [Related]
50. Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats.
Negus SS; Morrissey EM; Rosenberg M; Cheng K; Rice KC
Psychopharmacology (Berl); 2010 Jun; 210(2):149-59. PubMed ID: 20101391
[TBL] [Abstract][Full Text] [Related]
51. Naloxone-induced analgesia: involvement of kappa-opiate receptors.
Bianchi M; Panerai AE
Pharmacol Biochem Behav; 1993 Sep; 46(1):145-8. PubMed ID: 8255904
[TBL] [Abstract][Full Text] [Related]
52. Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia.
Pick CG; Peter Y; Schreiber S; Weizman R
Brain Res; 1997 Jan; 744(1):41-6. PubMed ID: 9030411
[TBL] [Abstract][Full Text] [Related]
53. Identification of short-acting κ-opioid receptor antagonists with anxiolytic-like activity.
Peters MF; Zacco A; Gordon J; Maciag CM; Litwin LC; Thompson C; Schroeder P; Sygowski LA; Piser TM; Brugel TA
Eur J Pharmacol; 2011 Jul; 661(1-3):27-34. PubMed ID: 21539838
[TBL] [Abstract][Full Text] [Related]
54. Pharmacology of opioid inhibition to noxious uterine cervical distension.
Sandner-Kiesling A; Eisenach JC
Anesthesiology; 2002 Oct; 97(4):966-71. PubMed ID: 12357166
[TBL] [Abstract][Full Text] [Related]
55. Expression and pharmacological modulation of visceral pain-induced conditioned place aversion in mice.
Bagdas D; Muldoon PP; AlSharari S; Carroll FI; Negus SS; Damaj MI
Neuropharmacology; 2016 Mar; 102():236-43. PubMed ID: 26639043
[TBL] [Abstract][Full Text] [Related]
56. The κ-opioid receptor antagonist JDTic decreases ethanol intake in alcohol-preferring AA rats.
Uhari-Väänänen J; Raasmaja A; Bäckström P; Oinio V; Carroll FI; Airavaara M; Kiianmaa K; Piepponen P
Psychopharmacology (Berl); 2018 May; 235(5):1581-1591. PubMed ID: 29492614
[TBL] [Abstract][Full Text] [Related]
57. Analogues of (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic). Synthesis and in vitro and in vivo opioid receptor antagonist activity.
Runyon SP; Brieaddy LE; Mascarella SW; Thomas JB; Navarro HA; Howard JL; Pollard GT; Carroll FI
J Med Chem; 2010 Jul; 53(14):5290-301. PubMed ID: 20568781
[TBL] [Abstract][Full Text] [Related]
58. The kappa-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety.
Marco EM; Llorente R; Pérez-Alvarez L; Moreno E; Guaza C; Viveros MP
Behav Brain Res; 2005 Sep; 163(2):212-8. PubMed ID: 15979169
[TBL] [Abstract][Full Text] [Related]
59. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA
J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
[TBL] [Abstract][Full Text] [Related]
60. Comparative hypotensive actions of three nonpeptide kappa opioid agonists on hippocampus of SHRs and normotensive WKY rats.
Zhai QZ; Ingenito AJ
J Cardiovasc Pharmacol; 1998 Jun; 31(6):806-12. PubMed ID: 9641463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
